SO
DYN icon

STRS Ohio’s Dyne Therapeutics DYN Stock Holding History

STRS Ohio’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,600
Closed -$50.9K – 2159
2025
Q4 		$50.9K Buy
+2,600
New +$49.2K ﹤0.01% 1975
2025
Q1 		– Sell
-1,100
Closed -$25.9K – 1957
2024
Q4 		$25.9K Sell
1,100
-9,500
-90% -$281K ﹤0.01% 1795
2024
Q3 		$381K Hold
10,600
– – ﹤0.01% 1366
2024
Q2 		$374K Sell
10,600
-9,800
-48% -$285K ﹤0.01% 1368
2024
Q1 		$579K Buy
+20,400
New +$461K ﹤0.01% 1157
2023
Q2 		– Sell
-13,200
Closed -$152K – 1989
2023
Q1 		$152K Hold
13,200
– – ﹤0.01% 1654
2022
Q4 		$152K Hold
13,200
– – ﹤0.01% 1646
2022
Q3 		$167K Buy
+13,200
New +$151K ﹤0.01% 1649
2021
Q1 		– Sell
-3,500
Closed -$73K – 2195
2020
Q4 		$73K Buy
+3,500
New +$69.2K ﹤0.01% 1945

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

STRS Ohio's DYN Position: Q1 2026 in Review

STRS Ohio sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 2,600 shares — an estimated $50.9K sold.

STRS Ohio first reported a position in DYN in Q4 2020 and held it in 9 quarters. The position peaked at $579K in Q1 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • STRS Ohio reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • STRS Ohio sold 2,600 Dyne Therapeutics shares in Q1 2026, an estimated $50.9K.
  • STRS Ohio first reported a position in Dyne Therapeutics in Q4 2020 and held it in 9 quarters.
  • STRS Ohio's Dyne Therapeutics position peaked at $579K in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.